Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Applied Materials Q1 EPS $2.03 Beats $1.93 Estimate, Sales $6.74B Beat $6.69B Estimate

Applied Materials (NASDAQ:AMAT) reported quarterly earnings of $2.03 per share which beat the analyst consensus estimate of $1.93 by 5.18 percent. This is a 7.41 percent increase over earnings of $1.89 per share from the
byBill Haddad
February 16, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Applied Materials (NASDAQ:AMAT) reported quarterly earnings of $2.03 per share which beat the analyst consensus estimate of $1.93 by 5.18 percent. This is a 7.41 percent increase over earnings of $1.89 per share from the same period last year. The company reported quarterly sales of $6.74 billion which beat the analyst consensus estimate of $6.69 billion by 0.73 percent. This is a 7.46 percent increase over sales of $6.27 billion the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Melt Pharmaceuticals’ MELT-300, Midazolam 3mg And Ketamine 50mg Sublingual Tablet, Achieves Top-Line Results In Primary Sedation Endpoint In Phase 2 Pivotal Efficacy And Safety Study

By Benzinga Newsdesk
December 21, 10:22 AM
  MELT-300 Statistically Superior for Procedural Sedation Compared to All Comparator Treatment Arms, Including Midazolam 3mg (P=0.0129) and Ketamine 50mg (P=0.0096) MELT-300 Treatment Arm 50% Less Likely to Require Rescue Sedation Compared to Midazolam (P=0.0198)

HROW